part 1: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
Published 11 years ago • 1K plays • Length 41:03Download video MP4
Download video MP3
Similar videos
-
32:17
part 2: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
10:49
part 3: clinical utility of angiogenesis inhibitors in metastatic colorectal cancer
-
18:58
mechanisms of angiogenesis inhibitors in metastatic colorectal cancer
-
15:55
enhancing outcomes in metastatic colorectal cancer with angiogenesis inhibitors
-
22:30
new directions in targeting angiogenesis for metastatic colorectal cancer
-
23:57
a comparison of angiogenesis inhibitor trial designs and outcomes in mcrc
-
10:54
metastatic gastric cancer: indications and impact of angiogenesis inhibitors
-
51:20
itesm cancer lectures: angiogenesis
-
1:50
dr. eckhardt discusses angiogenesis inhibitors in mcrc
-
35:27
expert perspectives: optimizing late-line therapy for patients with metastatic colorectal cancer
-
22:46
mutational testing and the treatment of colorectal cancer
-
2:34
dr. kunz on angiogenesis inhibitors for the treatment of metastatic gastric cancer
-
6:32
antiangiogenic therapy for metastatic colorectal cancer
-
5:04
a new hope
-
7:54
anti-angiogenesis drugs, part iii
-
18:04
why has everything beyond bevacizumab failed in angiogenesis inhibition?
-
5:08
sirflox impact on colorectal cancer management
-
25:27
angiogenesis and angiotherapy part 1
-
24:23
targeting angiogenesis in nsclc